CMS reveals 2008 Medicare Part D plans
CMS announces details of the 2008 prescription drug plans
Unapproved hydrocodone ordered off the market by FDA
FDA orders unapproved hydrocodone makers to cease marketing
AmerisourceBergen Teamsters rally for contract settlement
Teamsters at AmerisourceBergen to rally for fair contract settlement.
Albemarle: Price of ibuprofen to increase
Albemarle to increase price of ibuprofen
House passes bill to delay tamper-resistant Rx pad requirement
NACDS applauds passage of House bill to delay tamper-resistant paper requirement
New MTM plan in the works for Maryland and D.C.
QIO sets up new MTM program for Maryland and District of Columbia
PhRMA warns of drug counterfeiting threat
PhRMA testifies to Congress about the threat of drug counterfeiting
Wal-Mart expands $4 generic program
Wal-Mart expands its $4 generic plan to include more generics and adds birth control Rxs for $9.
Half of hospitals in Massachusetts no longer charge for errors
Massachusetts hospitals paying for errors
Fentora safety warning issued by FDA
FDA warns of adverse effects with buccal fentanyl use.
Senate passes bill to delay tamper-resistant pad rule
The Senate passed legislation delaying implementation of the Medicaid rule mandating tamper-resistant Rx pads and awaits House action.
DEA: Marijuana-related generic drugs belong under Schedule III
Generic versions of Marinol should be classified as Schedule III when they are approved, according to the Drug Enforcement Administration
Oncologists criticize CMS for upholding decision on ESA reimbursements
Medicare keeping limits on anemia drugs
Genetics a factor when using botanical supplements
Genetic differences predict anti-inflammatory benefits from nutritional products
Shop 'n Save to offer members health assessment
Shop 'n Save Pharmacy to provide Vitality Check wellness service
Role of community R.Ph.s highlighted in NACDS survey
NACDS Foundation Chain Pharmacy Industry Profile highlights role of pharmacists
New education center opens at University of Minnesota Duluth
College of Pharmacy gets new home
NACDS counters New York Times article
NACDS debunks New York Times article, "The 'Poisonous Cocktail' of Multiple Drugs"
Class-action AWP suits awaiting final settlements
Inflated average wholesale prices issued by two publishers have resulted in high costs for consumers, who have filed class-action suits against them.
DEA classifies oripavine as Schedule II
Oripavine is designated a Schedule II controlled substance by the Drug Enforcement Administration
NQF issues standards for substance abuse treatment
National Quality Forum releases standards for substance abuse treatment
On-line tool quantifies pain med usage
New on-line tool for calculating pain medication index
TWC Global recalls Axcil and Desirin supplements
TWC Global issues recall of Axcil and Desirin
Revision made to NCCN treatment guide for rare sarcoma
NCCN updates its dermatofibrosarcoma protuberans guidelines.
NCCN revises hepatobiliary cancer guide
NCCN updates hepatobiliary cancer treatment guidelines.
ASHP creates center for pharmacy workforce development
ASHP launches on-line resource center
CMS begins annual low-income subsidy reassessment
CMS outlines plans for contacting low-income subsidy beneficiaries for Medicare Part D program.
CVS/pharmacy to offer flu vaccinations
CVS/pharmacy to offer flu vaccinations in over 4,000 stores.
FDA warns about parasite in baby product
FDA warns about risk of Cryptosporidium illness from Baby's Bliss Gripe Water
Fla. pharmacist guilty in Internet scheme
Pharmacy owner pleads guilty to charges stemming from Affpower Internet pharmacy.
